Research

Advanced
Advanced

Reset

to
51 - 99 out of 99Page size: 50
  1. 2003
  2. Boonstra, R., Bosga - Bouwer, A., van Imhoff, G. W., Krause, V., Palmer, M., Coupland, R. W., Dabbagh, L., van den Berg, E., van den Berg, A., & Poppema, S. (2003). Splenic marginal zone lymphomas presenting with splenomegaly and typical immunophenotype are characterized by allelic loss in 7q31-32. Modern Pathology, 16(12), 1210-1217. https://doi.org/10.1097/01.MP.0000095895.19756.77
  3. 2002
  4. Bodmer, D., Janssen, N. V., Jonkers, Y., van den Berg, E., Dijkhuizen, T., Debiec-Rychter, M., Schoenmakers, E., & van Kessel, AG. (2002). Molecular cytogenetic analysis of clustered sporadic and familial renal cell carcinoma-associated 3q13 similar to q22 breakpoints. Cancer Genetics and Cytogenetics, 136(2), 95-100. [PII S0165-4608(02)00517-4].
  5. Kamps, WA., Bokkerink, JPM., Hakvoort-Cammel, FGAJ., Veerman, AJP., Weening, RS., van Wering, ER., van Weerden, JF., Hermans, J., Slater, R., van den Berg, E., Kroes, WG., & van der Does-van den Berg, A. (2002). BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996). Leukemia, 16(6), 1099-1111. https://doi.org/10.1038/sj/leu/2402489
  6. Fisher, C., van den Berg , E., & Molenaar, W. (2002). Adult fibrosarcoma. In CDM. Fletcher, KK. Unni, & F. Mertens (Eds.), World Health Organization Classification of Tumours : Pathology and Genetics of Tumours of Soft Tissue and Bone (pp. 100-101). IARC Press.
  7. Folpe, A., van den Berg, E., & Molenaar, W. (2002). Low grade fibromyxoid sarcoma. In World Health Organization Classification of Tumours : Pathology and Genetics of Tumours of Soft Tissue and Bone (pp. 104-105). IARC Press.
  8. Komdeur, R., Hoekstra, HJ., van den Berg, E., Molenaar, WM., Pras, E., de Vries, EGE., & van der Graaf, WTA. (2002). Metastasis in soft tissue sarcomas: Prognostic criteria and treatment perspectives. Cancer and metastasis reviews, 21(2), 167-183.
  9. Molenaar, W., & van den Berg, E. (2002). Myxofibrosarcoma. In CDM. Fletcher, KK. Unni, & F. Mertens (Eds.), World Health Organization Classification of Tumours : Pathology and Genetics of Tumours of Soft Tissue and Bone (pp. 102-103). IARC Press.
  10. Fletcher, CDM., van den Berg, E., & Molenaar, W. (2002). Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade sarcoma. In CDM. Fletcher, KK. Unni, & F. Mertens (Eds.), World Health Organization Classification of Tumours (pp. 120-122). IARC Press.
  11. Meis-Kindblom, JM., van den Berg, E., & Molenaar, W. (2002). Sclerosong epithelioid fibrosarcoma. In CDM. Fletcher, KK. Unni, & F. Mertens (Eds.), World Health Organization Clssification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. (pp. 106-107). IARC Press.
  12. Pijpe, J., Broers, G. H. T., Plaat, B. E. C., Hundeiker, M., Otto, F., Mastik, M. F., Hoekstra, H. J., Graaf, W. T. A. V. D., van den Berg, E., & Molenaar, W. M. (2002). The relation between histological, tumor-biological and clinical parameters in deep and superficial leiomyosarcoma and leiomyoma. Sarcoma, 6(3), 105-110. https://doi.org/10.1080/1357714021000065404
  13. 2001
  14. de Vries, EGE., Noordhoek, L., van den Berg, E., van der Pol, MA., Muller, M., & Vellenga, E. (2001). Activity and expression of the multidrug resistance proteins P-glycoprotein, MRP1, MRP2, MRP3 and MRP5 in de novo and relapsed acute myeloid leukemia. Leukemia, 15(10), 1544-1553.
  15. Slater, RM., Drunen, EV., Kroes, WG., Weghuis, DO., van den Berg, E., Smit, EM., van der Does-van den Berg, A., van Wering, E., Hahlen, K., Carroll, AJ., Raimondi, SC., & Beverloo, HB. (2001). t(7;12)(q36;p13) and t(7;12)(q32;p13) - translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Leukemia, 15(6), 915-920.
  16. Komdeur, R., Plaat, B., Hoekstra, H., Molenaar, W., Hollema, H., VANDENBERGDERUITER, E., & Mastik, M. (2001). Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Cancer, 91(10), 1940-1948. https://www.ncbi.nlm.nih.gov/pubmed/11346877
  17. van de Loosdrecht, AA., Brada, SJL., Blom, NR., Smit, JW., van den Berg, E., de Wolf, JTM., & Vellenga, E. (2001). Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis. Leukemia Research, 25(5), 385-393.
  18. Dijkhuizen, T., Jong, B. D., Meuzelaar, J. J., Molenaar, W. M., & van den Berg, E. (2001). No cytogenetic evidence for involvement of gene(s) at 2p16 in sporadic cardiac myxomas: cytogenetic changes in ten sporadic cardiac myxomas. Cancer Genetics and Cytogenetics, 126(2), 162-165.
  19. van de Loosdrecht, AA., de Wolf, JTM., Noordhoek, L., & van den Berg, E. (2001). Partial tetrasomy of 9p: A rare chromosomal abnormality in polycythaemia vera. British Journal of Haematology, 112(4), 1086-1087.
  20. Bosga-Bouwer, AG., Vellenga, E., Zorgdrager, H., & van den Berg, E. (2001). Cytogenetic analysis of cryopreserved bone marrow cells. Cancer Genetics and Cytogenetics, 124(2), 165-168.
  21. 2000
  22. van de Loosdrecht, AA., Kok, K., de Vries, B., van der Veen, AY., van den Berg, E., Esselink, MT., Marynen, P., Vellenga, E., & van Imhoff, GW. (2000). Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1. Leukemia, 14(10), 1857-1858.
  23. Plaat, BEC., Hollema, H., Molenaar, WM., Broers, GHT., Piipe, J., Mastik, MF., Hoekstra, HJ., van den Berg, E., Scheper, RJ., & van der Graaf, WTA. (2000). Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: Differences in clinical outcome and expression of multidrug resistance proteins. Journal of Clinical Oncology, 18(18), 3211-3220.
  24. Dam, A., Fock, J. M., Hayes, VM., Molenaar, WM., & van den Berg, E. (2000). Recurrent astrocytoma in a child: A report of cytogenetics and TP53 gene mutation screening. Neuro-Oncology, 2(3), 184-189. https://doi.org/10.1093/neuonc/2.3.184
  25. Vellenga, E., van der Veen, AY., Noordhoek, L., Timmer-Bosscha, H., Ossenkoppele, GJ., Raymakers, RA., Muller, M., van den Berg, E., & de Vries, EGE. (2000). Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity. Blood, 95(11), 3514-3519.
  26. Janssen, JJWM., van der Holt, B., Schuurhuis, GJ., Vellenga, E., Verhoef, GEG., Ossenkoppele, GJ., van den Berg, E., Hagemeijer, A., Slater, R., Nieuwint, AWM., & Cornelissen, JJ. (2000). Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests. Bone marrow transplantation, 25(11), 1147-1155.
  27. Plaat, B., Molenaar, WM., Sagrudny, J., Bohle, RM., Mastik, MF., Hoekstra, HJ., Van der Graaf, WTA., Hollema, H., & van den Berg, E. (2000). The 16p11 breakpoint in myxoid liposarcomas might affect the expression of the LRP gene on 16p11.2 encoding the multidrug resistance associated major vault protein. European Journal of Clinical Investigation, 30(5), 447-453.
  28. Simons, A., Schepens, M., Jeuken, J., Sprenger, S., van de Zande, G., Bjerkehagen, B., Forus, A., Weibolt, V., Molenaar, I., van den Berg-de Ruiter, E., Myklebost, O., Bridge, J., Geurts van Kessel, A., & Suijkerbuijk, R. (2000). Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genetics and Cytogenetics, 118(2), 89-98.
  29. 1999
  30. Kamps, WA., Bokkerink, JPM., Hahlen, K., Hermans, J., Riehm, H., Gadner, H., Schrappe, M., Slater, R., van den Berg-de Ruiter, E., Smets, LA., de Vaan, GAM., Weening, RS., van Weerden, JF., van Wering, ER., & van der Does-van den Berg, A. (1999). Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: Results of Dutch Childhood Leukemia Study Group protocol ALL-7 (1988-1991). Blood, 94(4), 1226-1236.
  31. Plaat, B. E., Molenaar, W. M., Mastik, M. F., Koudstaal, J., van den Berg-de Ruiter, E., Koops, H. S., & Hoekstra, H. J. (1999). Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: Treatment response and clinical outcome related to changes in proliferation and apoptosis. Clinical Cancer Research, 5(7), 1650-1657.
  32. Mastik, MF., Molenaar, WM., Plaat, B., de Graaf, S. S., Hogendoorn, PCW., van der Hout, AH., & van den Berg, E. (1999). Translocation (11;22)(q24;q12) in a small cell tumor of the thigh in a 2-year-old boy: Immunohistology, cytogenetics, molecular genetics, and review of the literature. Human Pathology, 30(3), 352-355.
  33. 1998
  34. Ham, SJ., van der Graaf, WTA., Pras, E., Molenaar, WM., van den Berg, E., & Hoekstra, HJ. (1998). Soft tissue sarcoma of the extremities. A multimodality diagnostic and therapeutic approach. CANCER TREATMENT REVIEWS, 24(6), 373-391. https://doi.org/10.1016/S0305-7372(98)90001-9
  35. Bos, SD., van den Berg, E., Dijkhuizen, T., van den Berg, A., Draaijers, TG., & Mensink, HJA. (1998). Genetic analysis of 2 cases of clear cell renal cancer in 2 sisters. International Journal of Cancer, 77(4), 494-497.
  36. Dijkhuizen, T., van den Berg, E., Storkel, S., & de Jong, B. (1998). Chromosome changes in a metastasis of a chromophobe renal cell tumor. Cancer Genetics and Cytogenetics, 105(1), 86-89.
  37. Dijkhuizen, T., Van Den Berg, E., Storkel, S., Terpe, HJ., Burger, H., & De Jong, B. (1998). Distinct features for chromophilic renal cell cancer with Xp11.2 breakpoints. Cancer Genetics and Cytogenetics, 104(1), 74-76.
  38. de Vries, EGE., Koning, JA., van den Berg, E., Muller, M., & Vellenga, E. (1998). Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral blood cells. Clinical Cancer Research, 4(7), 1727-1736.
  39. Bodmer, D., Eleveld, MJ., Ligtenberg, MJL., Weterman, MAJ., Janssen, BAP., Smeets, DFCM., de Wit, PEJ., van den Berg, A., van den Berg, E., Koolen, MI., & van Kessel, AG. (1998). An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation. American Journal of Human Genetics, 62(6), 1475-1483.
  40. Brada, SJL., de Wolf, JTM., Louwes, H., van den Berg, E., & Vellenga, E. (1998). Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor. British Journal of Haematology, 102(3), 340-345.
  41. Speleman, F., van den Berg, E., Dhooge, C., Oosterhuis, W., Redeker, B., De Potter, CR., Tamminga, RYJ., Van Roy, N., & Mannens, M. (1998). Cytogenetic and molecular analysis of cellular atypical mesoblastic nephroma. GENES CHROMOSOMES & CANCER, 21(3), 265-269.
  42. Daenen, S., Van Imhoff, GW., Van den Berg, E., De Kam, PJ., Haaxma-Reiche, H., Vellenga, E., Smit, JW., & Halie, RM. (1998). Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a 'pre-induction' course for rapid tumour reduction: preliminary results on 66 patients. British Journal of Haematology, 100(2), 273-282.
  43. 1996
  44. Dijkhuizen, T., van den Berg , E., van den Berg, A., Storkel, S., DeJong, B., Seitz, G., & Henn, W. (1996). Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas. International Journal of Cancer, 68(1), 47-50. https://doi.org/10.1002/(SICI)1097-0215(19960927)68:1<47::AID-IJC9>3.0.CO;2-X
  45. Plaat, B. E. C., Sars, P., Mastik, M. F., Molenaar, W. M., Hoekstra, H. J., & van den Berg, E. (1996). Chromosomal analysis in non-myxoid and dedifferentiated myxoid liposarcomas. Cancer Genetics and Cytogenetics, 91, 146.
  46. Molenaar, W. M., van den Berg, E., Dijkhuizen, T., & Hoekstra, H. J. (1996). Cytogenetics of borderline malignant soft tissue tumors: An aid for the histopathological diagnosis. Cancer Genetics and Cytogenetics, 91, 154. https://doi.org/10.1016/S0165-4608(97)82610-6
  47. Mastik, M. F., Plaat, B. E. C., Molenaar, W. M., Hoekstra, H. J., de Graaf, S. S. N., & van den Berg, E. (1996). t(11;22)(q24;q12) in an extrarenal malignant rhabdoid tumor. Cancer Genetics and Cytogenetics, 91, 164.
  48. 1995
  49. Dijkhuizen, T., Van den Berg, E., Wilbrink, M., Weterman, M., Geurts van Kessel, A., Störkel, S., Folkers, R. P., Braam, A., & De Jong, B. (1995). Distinct Xp11.2 breakpoints in two renal cell carcinomas exhibiting X;autosome translocations. GENES CHROMOSOMES & CANCER, 14(1), 43-50. https://doi.org/10.1002/gcc.2870140108
  50. Dijkhuizen, T., van den Berg, E., Molenaar, W. M., Meuzelaar, J. J., & de Jong, B. (1995). Rearrangements involving 12p12 in two cases of cardiac myxoma. Cancer Genetics and Cytogenetics, 82(2), 161-162.
  51. Echten, J. V., van den Berg-de Ruiter, E., Baarlen, J. V., Noort, G. V., Vermey, A., Dam, A., & Molenaar, W. M. (1995). An important role for chromosome 17, band q25, in the histogenesis of alveolar soft part sarcoma. Cancer Genetics and Cytogenetics, 82(1), 57-61.
  52. 1994
  53. van den Berg, E., Molenaar, W. M., Echten, J. V., Dam, A., Mensink, H. J., & Jong, B. D. (1994). Cytogenetic analysis of a leiomyosarcoma of the kidney. Cancer Genetics and Cytogenetics, 72(2), 126-129. https://doi.org/10.1016/0165-4608(94)90127-9
  54. Weghuis, D. O., Stoepker, M. E., Leeuw, B. D., van den Berg, E., Suijkerbuijk, R. F., Molenaar, W. M., Jong, B. D., & Kessel, A. G. V. (1994). A synovial sarcoma with a complex t(X;18;5;4) and a break in the ornithine aminotransferase (OAT)L1 cluster on Xp11.2. GENES CHROMOSOMES & CANCER, 9, 288-291.
  55. van den Berg, E., Oven, M. W. V., de Jong, B., Dam, A., Wiersema, J., Dijkhuizen, T., Hoekstra, H. J., & Molenaar, W. M. (1994). Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Laboratory Investigation, 70(3), 307-313.
  56. Leeuw, B. D., Suijkerbuijk, R. F., Weghuis, D. O., Meloni, A. M., Stenman, G., Kindblom, L. G., Balemans, M., van den Berg, E., Molenaar, W. M., & Sandberg, A. A. (1994). Distinct Xp11.2 breakpoint regions in synovial sarcoma revealed by metaphase and interphase FISH: relationship to histologic subtypes. Cancer Genetics and Cytogenetics, 73(2), 89-94.
  57. 1993
  58. Hout, van der, AH., van den Berg, E., van der Vlies, P., Dijkhuizen, T., Störkel, S., Oosterhuis, JW., de Jong, B., & Buys, CHCM. (1993). Loss of heterozygosity at the short arm of chromosome 3 in renal‐cell cancer correlates with the cytological tumour type. International Journal of Cancer, 53(3), 353-357. https://doi.org/10.1002/ijc.2910530302
  59. van den Berg-de Ruiter, E. (1993). Order and complexity in renal cell tumors. A cytogenetic, molecular genetic and histopathological study. Stichting Drukkerij C. Regenboog.
Previous 1 2 Next

ID: 136108

University of Groningen staff: edit these data

print